Evidence Bio

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.

Pneumagen

This clinical-stage biotech company develops intranasal antiviral drugs to prevent and treat respiratory tract infections for patients with chronic lung diseases.

Clarametyx Biosciences

This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.

Eradivir

This biotechnology company develops small molecule immunotherapies that target viral infections and cancers for healthcare providers and patients.

Edesa Biotech

This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.

Upstream Bio

The company develops monoclonal antibody therapies for patients with chronic inflammatory and respiratory diseases, including asthma and chronic rhinosinusitis.